Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostate-specific antigen (PSA) is a protein produced almost exclusively by cells of the prostate gland. It functions as an androgen-regulated serine protease enzyme and its main physiological role is to cleave semenogelins within the seminal coagulum, aiding sperm motility by liquefying seminal fluid after ejaculation. Clinically, PSA is primarily used as a biomarker for screening, diagnosis, and monitoring prostate cancer. Elevated serum PSA can also result from benign conditions such as benign prostatic hyperplasia (BPH) or prostatitis.
Inhibitors being developed; currently primarily used as a biomarker
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostate Specific Antigen (PSA).